Search
Search Results
##search.searchResults.foundPlural##
-
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3268PDF: 1180HTML: 1687Untitled: 206Untitled: 196Untitled: 193 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1549PDF: 1011HTML: 515 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2667PDF: 855HTML: 382Figure 1: 197 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1786PDF: 777HTML: 2354 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1354PDF: 894HTML: 141 -
SOLITARY PLASMACYTOMA
4204PDF: 2248HTML: 1407fIGURES 1,2: 256 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1965PDF: 1045HTML: 248 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1673PDF: 817HTML: 1335 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
815PDF: 690HTML: 129 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6477PDF: 2208HTML: 14154Untitled: 224figure: 209 -
PROPHYLAXIS OF MALARIA
3107PDF: 1079HTML: 17995Figures SChwartz: 189 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2577PDF: 826HTML: 1748 -
-
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1478PDF: 496HTML: 182 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
3873PDF: 948HTML: 470Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 217 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2849PDF: 1126HTML: 2636 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3203PDF: 930HTML: 7308Kost Fig1: 215Kost Fig 2: 201Kost Fig3: 208Kost Fig 4: 220Kost Fig5: 218Kost fig 6: 205 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1634PDF: 804HTML: 2189Untitled: 253Untitled: 224Untitled: 212Untitled: 231Untitled: 229 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1024PDF: 556HTML: 334 -
Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major
799PDF: 601HTML: 194







